ASCENDIS PHARMA TO LIST ORDINARY SHARES DIRECTLY ON NASDAQ
ASCENDIS PHARMA - ORDINARY SHARES EXPECTED TO COMMENCE TRADING ON NASDAQ ON APRIL 20, 2026 FOLLOWING EXCHANGE OF ALL AMERICAN DEPOSITARY SHARES
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.